XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3Close
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities    
Net income $ 3,594 $ 5,139
Adjustments to net income:    
Depreciation 1,092 853
Amortization of capitalized software 53 48
Stock compensation 309 294
Gains on sales of assets (126) (1)
Deferred taxes (189) (159)
Increase (decrease) from changes in:    
Accounts receivable (75) (81)
Inventories (297) (1,151)
Prepaid expenses and other current assets (69) 38
Accounts payable and accrued expenses 38 (23)
Accrued compensation (127) (97)
Income taxes payable 487 (65)
Changes in funded status of retirement plans 2 49
Other (372) (348)
Cash flows from operating activities 4,320 4,496 Close
Cash flows from investing activities    
Capital expenditures (3,628) (3,923)
Proceeds from asset sales 194 3
Purchases of short-term investments (8,807) (10,140)
Proceeds from short-term investments 8,461 9,976
Other (36) 33
Cash flows from investing activities (3,816) (4,051) Close
Cash flows from financing activities    
Proceeds from issuance of long-term debt 2,980 3,000
Repayment of debt (300) (500)
Dividends paid (3,555) (3,376)
Stock repurchases (392) (228)
Proceeds from common stock transactions 430 218
Other (42) (43)
Cash flows from financing activities (879) (929) Close
Net change in cash and cash equivalents (375) (484) Close
Cash and cash equivalents at beginning of period 2,964 3,050
Cash and cash equivalents at end of period 2,589 2,566
Supplemental cash flow information    
Investment tax credit (ITC) used to reduce income taxes payable 532 0
Total cash benefit related to the U.S. CHIPS and Science Act $ 532 $ 0